Title:
ENVIRONMENTAL CLOSTRIDIAL BACTERIOTHERAPY AND RELATED FORMULATIONS AND METHODS OF MANUFACTURE AND USE
Document Type and Number:
WIPO Patent Application WO/2012/033814
Kind Code:
A3
Abstract:
Compositions and methods for inhibiting Clostridium associated diseases are disclosed.
More Like This:
Inventors:
TATAROWICZ WALTER A (US)
BROOM COLIN (US)
BROOM COLIN (US)
Application Number:
PCT/US2011/050657
Publication Date:
June 07, 2012
Filing Date:
September 07, 2011
Export Citation:
Assignee:
VIROPHARMA INC (US)
TATAROWICZ WALTER A (US)
BROOM COLIN (US)
TATAROWICZ WALTER A (US)
BROOM COLIN (US)
International Classes:
A61K35/74; A61K39/08
Foreign References:
| US6635260B1 | 2003-10-21 |
Other References:
MERRIGAN M.M. ET AL.: "New approach to the management of Clostridium difficile infection: colonisation with non-toxigenic C. difficile during daily ampicillin or ceftriaxone administration.", INT J ANTIMICROB AGENTS, vol. 33, no. 1, 2009, pages S46 - S50, XP026010683
SUN ET AL.: "Recent Development in the Treatment of Clostridium difficile Associated Disease (CDAD).", ANNUAL REPORTS IN MEDICINAL CHEMISTRY, vol. 43, 2008, pages 269 - 279, XP009184643, DOI: doi:10.1016/S0065-7743(08)00016-X
BEST E.L. ET AL.: "The potential for airborne dispersal of Clostridium difficile from symptomatic patients.", CLIN INFECT DIS., vol. 50, no. 11, 1 June 2010 (2010-06-01), pages 1450 - 1457, XP055082484
ROBERTS K. ET AL.: "Aerial dissemination of Clostridium difficile spores", BMC INFECT DIS., vol. 8, no. 7, 2008, pages 1 - 6, XP021034243
SEAL D. ET AL.: "Treatment of relapsing Clostridium difficile diarrhoea by administration of a non- toxigenic strain.", EUR J CLIN MICROBIOL., vol. 6, no. 1, February 1987 (1987-02-01), pages 51 - 53, XP000985052
VENUTO ET AL.: "Alternative therapies for Clostridium difficile infections", PHARMACOTHERAPY, vol. 30, no. 12, December 2010 (2010-12-01), pages 1266 - 1278, XP055096655
GERDING D.N. ET AL.: "Management of Clostridium difficile infection: thinking inside and outside the box.", CLIN INFECT DIS., vol. 51, no. 11, 27 October 2010 (2010-10-27), pages 1306 - 1313, XP055082486
SUN ET AL.: "Recent Development in the Treatment of Clostridium difficile Associated Disease (CDAD).", ANNUAL REPORTS IN MEDICINAL CHEMISTRY, vol. 43, 2008, pages 269 - 279, XP009184643, DOI: doi:10.1016/S0065-7743(08)00016-X
BEST E.L. ET AL.: "The potential for airborne dispersal of Clostridium difficile from symptomatic patients.", CLIN INFECT DIS., vol. 50, no. 11, 1 June 2010 (2010-06-01), pages 1450 - 1457, XP055082484
ROBERTS K. ET AL.: "Aerial dissemination of Clostridium difficile spores", BMC INFECT DIS., vol. 8, no. 7, 2008, pages 1 - 6, XP021034243
SEAL D. ET AL.: "Treatment of relapsing Clostridium difficile diarrhoea by administration of a non- toxigenic strain.", EUR J CLIN MICROBIOL., vol. 6, no. 1, February 1987 (1987-02-01), pages 51 - 53, XP000985052
VENUTO ET AL.: "Alternative therapies for Clostridium difficile infections", PHARMACOTHERAPY, vol. 30, no. 12, December 2010 (2010-12-01), pages 1266 - 1278, XP055096655
GERDING D.N. ET AL.: "Management of Clostridium difficile infection: thinking inside and outside the box.", CLIN INFECT DIS., vol. 51, no. 11, 27 October 2010 (2010-10-27), pages 1306 - 1313, XP055082486
Attorney, Agent or Firm:
NETTER, Robert, C., Jr. et al. (Dorfman Herrell & Skillman,1601 Market Street, Suite 240, Philadelphia PA, US)
Download PDF:
Previous Patent: COMPOSITIONS FOR DYEING KERATIN FIBERS
Next Patent: ARYLPROPIONYL-ALPHA-PYRONE ANTIBACTERIAL AGENTS
Next Patent: ARYLPROPIONYL-ALPHA-PYRONE ANTIBACTERIAL AGENTS